KVD-818

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKVD-818
Drug Alias NameKVD-818
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsEdema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKalvista Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKalvista Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsEdema

Other Information

ATC CodeN/A
Related LinksN/A